Sandbox:Sahar: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
{{Family tree | | |!| | |!| | }} | {{Family tree | | |!| | |!| | }} | ||
{{familytree | | | H02 |'| | | |H02=All the relatives should be evaluated for the presence of paragnaglioma}} | {{familytree | | | H02 |'| | | |H02=All the relatives should be evaluated for the presence of paragnaglioma}} | ||
{{Family tree | | | |!| | | | }} | |||
{{Family tree | | | I01 | | | |I01= whole-body 18F-dihydroxyphenylalanine (F-DOPA) positron emission tomography to assess the presence of other paragangliomas}} | |||
{{Family tree |,|-|-|^|-|-|.| |}} | |||
{{Family tree/end}} | {{Family tree/end}} | ||
Revision as of 14:59, 8 April 2019
| Patient with neck mass suspected to carotid body tumor | |||||||||||||||||||||||||||
| History, Physical examination, and evaluation of cnotralateral side | |||||||||||||||||||||||||||
| Patients with age < 50 years Patients with multiple paraganglioma Patients with a positive family history | The rest of the patients | ||||||||||||||||||||||||||
| SDHD genetic testing | |||||||||||||||||||||||||||
| Presence of SDHD mutation | Absence of SDHD mutation | ||||||||||||||||||||||||||
| SDHC and SDHB genetic testing | |||||||||||||||||||||||||||
| Presence of SDHC/B mutation | Absence of SDHC/B mutation | ||||||||||||||||||||||||||
| All the relatives should be evaluated for the presence of paragnaglioma | |||||||||||||||||||||||||||
| whole-body 18F-dihydroxyphenylalanine (F-DOPA) positron emission tomography to assess the presence of other paragangliomas | |||||||||||||||||||||||||||